Anti-anxiety effect of Valeriana jatamansi Jones extract via regulation of the hypothalamus-pituitary-adrenal axis

查看全文 作　　者：Zhiyong [1]Yan;Tian'e [2]Zhang;Ting [1]Xiao;Lingzhen [1]Pan;Jinzhi [1]Qin;Zhanping [1]Zhang;Changying [1]Zuo

机构地区：[1]Department of Pharmacy, School of Life Science and Engineering, Southwest Jiaotong University, Chengdu 610031, Sichuan Province,China;[2]College of Basic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu 610075, Sichuan Province, China

出　　处：《Neural Regeneration Research》索引2010年第5卷第14期,共5页

基　　金：Project of Sichuan Provincial Traditional Chinese Medicine Administration,No.200674;Science Foundation of Southwest Jiaotong University,No.2006A10;'Key New Drug Innovation' National Science and Technology Major Projects During Eleventh Five-Year Plan,No.2009ZX09103-370;Chengdu Science and Technology Major Projects During Eleventh Five-Year Plan,No.09GGZD060SF-012 摘　　要：BACKGROUND:Hypothalamus-pituitary-adrenal (HPA) axis dysfunction has been closely linked to anxiety.Previous studies have shown that Valeriana jatamansi Jones extract exhibits clear anxio-lytic effects, but it is unclear about the mechanism underlying regulation of the HPA axis dysfunction in these anxiolytic effects.OBJECTIVE:To observe the effects of Valeriana jatamansi Jones (Zhizhu Xiang) extract on HPA axis function in a rat model of anxiety, and to compare these effects with positive control estazolam.DESIGN, TIME AND SETTING:Randomized, controlled, animal experiment was performed at Chengdu University of Traditional Chinese Medicine, China, between February and September in 2006.MATERIALS:Estazolam was purchased from Shanghai Jiufu Pharmaceutical, China; Valeriana jatamansi Jones was purchased from the Lotus Pond Market for Chinese Herbal Medicine in Chengdu.It consisted of iridoids and flavonoid components.METHODS:A total of 72 Sprague Dawley rats, aged 2 months, were randomly assigned to 6 groups:low-, medium-, and high-dose Valeriana jatamansi Jones groups intragastrically injected with 0.3, 0.6, and 0.9 g/kg per day Valeriana jatamansi Jones extract, respectively; estazolam group intragastrically injected with 1.5 mg/kg per day estazolam; model and normal groups administered 5 mL physiological saline.Anxiety was established in all groups, except the normal group, through the use of elevated plus-maze test at 7 days following drug administration.MAIN OUTCOME MEASURES:Blood β-endorphin and corticosterone levels were determined using enzyme-linked immunosorbent assay following treatment with Valeriana jatamansi Jones extract.Expressions of HPA axis-related genes were measured by cDNA microarray.RESULTS:Blood β-endorphin and corticosterone levels were significantly greater in the model group than in the normal group.Compared with the model group, levels decreased with Valeriana jatamansi Jones extract or estazolam treatment, particularly in the low-dose Valeriana jatamansi Jones group (P<0.01).cDNA microarray results demonstrated that corticotropin-releasing hormone and Orexin, which are associated with HPA axis function, were differentially expressed; expression increased in the model group, but decreased in rats treated with Valeriana jatamansi Jones extract.CONCLUSION:Valeriana jatamansi Jones extract plays a role in regulating HPA axis function in a rat model of anxiety, and this effect was superior to estazolam. 关键词：提取物下丘脑焦虑轴功缬草酶联免疫吸附试验促肾上腺皮质激素黄酮类成分

相关文献

参考文献（29）
引证文献（9）
耦合文献（120）

参考文献(29)

引证文献(9)

耦合文献(120)

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

Anti-anxiety effect of Valeriana jatamansi Jones extract via regulation of the hypothalamus-pituitary-adrenal axis

参考文献(29)

引证文献(9)

耦合文献(120)

用户提示